UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

The American journal of gastroenterology, 2017-03, Vol.112 (3), p.441-446

2017

Volltextzugriff (PDF)

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

Health and quality of life outcomes, 2008-04, Vol.6 (1), p.31-31, Article 31

2008

Volltextzugriff (PDF)

Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis

Clinical gastroenterology and hepatology, 2009-12, Vol.7 (12), p.1292-1298

2009

Volltextzugriff (PDF)

Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study

Scandinavian journal of gastroenterology, 2012-12, Vol.47 (12), p.1429-1435

2012

Volltextzugriff (PDF)

Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative

The American journal of gastroenterology, 2004-09, Vol.99 (9), p.1652-1656

2004

Volltextzugriff (PDF)

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

JAMA : the journal of the American Medical Association, 2011-05, Vol.305 (19), p.1969

2011

Volltextzugriff (PDF)

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

Gut, 2010-06, Vol.59 (6), p.714-721

2010

Volltextzugriff (PDF)

Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease

Clinical gastroenterology and hepatology, 2012-12, Vol.10 (12), p.1360-1366

2012

Volltextzugriff (PDF)

Effect of Esomeprazole 40 mg Once or Twice Daily on Asthma: A Randomized, Placebo-controlled Study

American journal of respiratory and critical care medicine, 2010-05, Vol.181 (10), p.1042-1048

2010

Volltextzugriff (PDF)

Meaning, Power and Exoticism in Medicinal Music: A Case Study of MusiCure in Denmark

Ethnomusicology forum, 2007-11, Vol.16 (2), p.209-242

Lind, Tore Tvarnø

2007

Volltextzugriff (PDF)

Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study

Gastroenterology (New York, N.Y. 1943), 2005-12, Vol.129 (6), p.1825-1831

2005

Volltextzugriff (PDF)

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

The American journal of gastroenterology, 2017-03, Vol.112 (3), p.441-446

2017

Volltextzugriff (PDF)

Time Course of Improvement in the Frequency and Intensity of Heartburn With Esomeprazole 20 Mg over 14 Days of Treatment: 2253

The American journal of gastroenterology, 2015-10, Vol.110, p.S936

2015

Volltextzugriff (PDF)

Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study

Gut, 2007-05, Vol.56 (5), p.615-620

2007

Volltextzugriff (PDF)

Erosive Esophagitis Is a Risk Factor for Barrett's Esophagus: A Community-Based Endoscopic Follow-Up Study

The American journal of gastroenterology, 2011-11, Vol.106 (11), p.1946-1952

2011

Volltextzugriff (PDF)

Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-Term Esomeprazole Therapy

Clinical gastroenterology and hepatology, 2016-05, Vol.14 (5), p.678-685.e3

2016

Volltextzugriff (PDF)

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial

Annals of internal medicine, 2009-04, Vol.150 (7), p.455

2009

Volltextzugriff (PDF)

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report

Scandinavian journal of gastroenterology, 2005-02, Vol.40 (3), p.275-285

2005

Volltextzugriff (PDF)

Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding

Journal of digestive diseases, 2017-02, Vol.18 (2), p.99-106

2017

Volltextzugriff (PDF)

Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease

The American journal of gastroenterology, 2006-11, Vol.101 (11), p.2457-2462

2006

Volltextzugriff (PDF)

Identifying Clinical Predictors of Heartburn Resolution With Over-the-Counter Esomeprazole: 2256

The American journal of gastroenterology, 2015-10, Vol.110, p.S937

2015

Volltextzugriff (PDF)

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

European journal of clinical pharmacology, 2004-10, Vol.60 (8), p.531-539

2004

Volltextzugriff (PDF)

Cost of Detecting Malignant Lesions by Endoscopy in 2741 Primary Care Dyspeptic Patients Without Alarm Symptoms

Clinical gastroenterology and hepatology, 2009-07, Vol.7 (7), p.756-761

2009

Volltextzugriff (PDF)

Tu1117 Resolution and Early Relief of Frequent Heartburn With a 14-Day Regimen of Esomeprazole 20 mg: Results From 2 Multicenter, Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-758-S-759

2014

Volltextzugriff (PDF)

Tu1116 A 14-Day Regimen of Esomeprazole 20 mg Was Effective in Increasing Heartburn-Free 24-Hour Days: Results From 2 Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-758-S-758

2014

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(53)
Humans
(47)
Middle Aged
(37)
Male
(36)
Female
(33)
Adult
(31)
Gastroenterology And Hepatology
(30)
Gastroenterology & Hepatology
(29)
Aged
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Treatment Outcome
(19)
Gastroenterology. Liver. Pancreas. Abdomen
(14)
Gastroesophageal Reflux - Drug Therapy
(14)
Medicin Och Hälsovetenskap
(13)
Other Diseases. Semiology
(13)
Gastroenterology
(12)
Gastroesophageal Reflux
(12)
Esophagus
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis

Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study

Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease

Effect of Esomeprazole 40 mg Once or Twice Daily on Asthma: A Randomized, Placebo-controlled Study

Meaning, Power and Exoticism in Medicinal Music: A Case Study of MusiCure in Denmark

Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study

Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial

Time Course of Improvement in the Frequency and Intensity of Heartburn With Esomeprazole 20 Mg over 14 Days of Treatment: 2253

Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study

Erosive Esophagitis Is a Risk Factor for Barrett's Esophagus: A Community-Based Endoscopic Follow-Up Study

Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-Term Esomeprazole Therapy

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report

Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding

Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease

Identifying Clinical Predictors of Heartburn Resolution With Over-the-Counter Esomeprazole: 2256

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

Cost of Detecting Malignant Lesions by Endoscopy in 2741 Primary Care Dyspeptic Patients Without Alarm Symptoms

Tu1117 Resolution and Early Relief of Frequent Heartburn With a 14-Day Regimen of Esomeprazole 20 mg: Results From 2 Multicenter, Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications

Tu1116 A 14-Day Regimen of Esomeprazole 20 mg Was Effective in Increasing Heartburn-Free 24-Hour Days: Results From 2 Randomized, Double-Blind Trials in Subjects With Frequent Heartburn Who Are Likely to Self-Treat With Over-the-Counter Medications

Suchergebnisse filtern